MYD88 and Atrophy: In summary, tubular atrophy and interstitial fibrosis after UUO develop independent of the TLR signaling inhibitor SIGIRR mainly because TLR2, TLR9, and their essential adaptor molecule and SIGIRR's interaction target MyD88 do not significantly contribute to the postobstructive renal inflammation and tissue remodeling.